JP Morgan Chase & Co (JPM) 58.83 $JPM
US stocks head lower; crude oil price falls again
By MATTHEW CRAFT - AP - 2 mins ago
NEW YORK (AP) — Falling oil prices dragged the stock market lower on Monday as Exxon Mobil, Chevron and other big energy companies sank along with crude.
ABC: 90.93 (-2.07), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), XOM: 90.33 (-1.77), TIF: 89.01 (-14.44), CVX: 105.88 (-2.33)
ProNAi to Present at the 33rd Annual J.P. Morgan Healthcare Conference
CNW Group - 26 mins ago
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi(®) platform, today announced that it has been invited to present at the 33(rd) Annual J.P. Morgan Healthcare Conference being held this week in San Francisco. Dr. Nick Glover, President and CEO of ProNAi, will provide an update on the Company's development program for its lead DNAi therapeutic, PNT2258, on January 15, 2015 at 11:30 a.m. PST in room Elizabethan D.
JPM: 58.83 (-0.51)
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
Business Wire - 27 mins ago
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.
JPM: 58.83 (-0.51), GILD: 101.21 (-1.00)
Universal Corp. (UVV) Continues to Strengthen Balance Sheet - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 52 mins ago
Last week, Universal Corporation completed its new bank credit facility agreement.
RAI: 65.64 (+0.66), JPM: 58.83 (-0.51), STI: 38.41 (-0.41), UVV: 39.33 (-0.09)
Burlington Stores, Inc. Announces Secondary Offering of Common Stock
Business Wire - 55 mins ago
Burlington Stores, Inc. (NYSE:BURL) (the "Company"
announced today that affiliates of Bain Capital Partners, LLC and certain other stockholders intend to offer 12,500,000 shares of the Company's common stock in an underwritten public offering. The offering consists entirely of secondary shares to be sold by the selling stockholders. The Company will not sell any shares in the offering and will not receive any proceeds from the offering.
JPM: 58.83 (-0.51), BURL: 49.29 (+1.29)
Skilled Healthcare Group and Genesis HealthCare to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 15, 2015
PR Newswire - 1 hr 12 mins ago
Skilled Healthcare Group, Inc. (NYSE: SKH) today announced that Robert Fish, Chief Executive Officer of Skilled Healthcare Group and George V. Hager, Jr., Chief Executive Officer of Genesis HealthCare, LLC, are scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at 9:30 am Pacific Time. The conference is being held at the Westin St. Francis Hotel, San Francisco, CA.
JPM: 58.83 (-0.51), SKH: 8.61 (+0.25)
Aircastle Announces Pricing of $500 Million Aggregate Principal Amount of Senior Notes
PR Newswire - 1 hr 12 mins ago
Aircastle Limited (NYSE: AYR) ("Aircastle" announced today the pricing of $500 million aggregate principal amount of 5.50% senior notes due 2022 (the "notes" . The notes were priced at par. Aircastle plans to use the net proceeds of the offering for general corporate purposes, which may include repayment of indebtedness.
JPM: 58.83 (-0.51), DB: 28.23 (-0.01), AYR: 20.48 (+0.31)
Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration
GlobeNewswire - 1 hr 15 mins ago
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that its collaboration partner Celgene Corporation has agreed that it will exercise its option to obtain an exclusive license outside the United States for AG-120, a first-in-class, oral, potent inhibitor of the mutant IDH1 protein under the terms of the 2010 collaboration agreement. This would be the second IDH mutant inhibitor to be licensed by Celgene in less than a year. AG-120 is currently being evaluated in two Phase 1 dose escalation trials, one in advanced hematologic malignancies and the other in advanced solid tumors. Both trials are evaluating AG-120 in patients whose cancer harbors an IDH1 mutation. The first data from the AG-120 program were presented at the EORTC-NCI-AACR Symposium on November 19, 2014 in advanced hematologic malignancies. Agios expects to report the first data from the Phase 1 advanced solid tumor trial at a medical conference in 2015. Celgene's exercise of the option is subject to receipt of any required regulatory approvals including any applicable clearance under the Hart-Scott-Rodino Act. Agios is webcasting its corporate presentation from the 33 Annual J.P. Morgan Healthcare Conference today at 2:30 p.m. PST (5:30 p.m. EST). The presentation will be followed by a webcast of its question and answer session at 3:00 p.m. PST (6:00 p.m. EST).
JPM: 58.83 (-0.51), AGIO: 131.55 (+3.43), CELGZ: 3.41 (+0.13)
Dynavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - 1 hr 21 mins ago
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2015 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
DVAX: 18.58 (+0.87), JPM: 58.83 (-0.51)
Earnings Season Arrives but Markets Can't Stop Worrying About Oil
at The Street - 1 hr 23 mins ago
The earnings season officially kicks off this afternoon with the release of Alcoa AA quarterly earnings, but oil prices remain at the forefront of traders' minds.
C: 50.38 (-0.40), XOM: 90.33 (-1.77), WFC: 52.05 (-0.63), SN: 8.56 (-0.32), BAC: 16.68 (-0.30), INTC: 36.60 (-0.16), AA: 16.17 (+0.06), GS: 185.07 (-2.28), RDS.A: 62.93 (-1.29), JPM: 58.83 (-0.51), BBG: 9.42 (-0.70), REXX: 2.94 (-0.74), BP: 36.05 (-0.53), BAS: 5.44 (-0.66), CVX: 105.88 (-2.33)
Looking Ahead Of Wall Street: J.P Morgan Chase, Bank Of America, Citigroup
TipRanks - Seeking Alpha - 1 hr 26 mins ago
By Carly Forster Wall Street has an exciting week ahead as investment banks are scheduled to announce their fourth quarter fiscal 2014 earnings reports. J.P Morgan Chase: J.P Morgan Chase (NYSE: JPM ) is set to announce their fourth quarter...
JPM: 58.83 (-0.51), C: 50.38 (-0.40), BAC: 16.68 (-0.30)
Obama: With tech advances come privacy risks for US
By NEDRA PICKLER - AP - 1 hr 30 mins ago
WASHINGTON (AP) — President Barack Obama on Monday proposed strengthening laws against identity theft by requiring notification when consumer information is hacked and protecting students' private data.
JPM: 58.83 (-0.51), TGT: 76.63 (+0.20)
JPMorgan to Settle Bear Stearns Mortgage Case for $500M? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 47 mins ago
2015 started on a positive note for JPMorgan as far as the resolution of litigation issues is concerned. After settling a lawsuit for foreign exchange market price manipulation last week, the bank is on the verge of resolving another case.
JPM: 58.83 (-0.51), AMG: 201.59 (-3.75), WAL: 25.58 (-0.43), NAVI: 20.17 (-0.37)
Millions more people to get their credit score for free
By JOSEPH PISANI - AP - 2 hrs 1 min ago
NEW YORK (AP) — Millions more people will have free access to their FICO credit score this year. That's good news for consumers, since the number is widely used by lenders to check potential borrowers' financial health.
DFS: 63.02 (-0.30), COF: 79.06 (-0.31), JPM: 58.83 (-0.51), ALLY: 22.57 (-1.31), C: 50.38 (-0.40), FICO: 70.96 (-0.87), BAC: 16.68 (-0.30)
Do Rising Auto Delinquencies Spell Trouble Ahead?
ETFguide - Seeking Alpha - Mon Jan 12, 12:04PM CST
By Ronald Delegge Is consumer credit quality deteriorating? TransUnion reports: While delinquency levels for subprime borrowers have grown from 4.2% in Q3 2012 to 4.5% in Q3 2013 to 5.3% in Q3 2014, the contribution of this segment to the...
COF: 79.06 (-0.31), JPM: 58.83 (-0.51), ALLY: 22.57 (-1.31), XLY: 70.51 (-0.38), CARZ: 36.92 (-0.08), WFC: 52.05 (-0.63)
Medtronic Highlights Growth Opportunities at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Mon Jan 12, 12:00PM CST
SAN FRANCISCO -- Jan. 12, 2015 -- Chairman and CEO Omar Ishrak discussed the future of Medtronic, Inc. (NYSE: MDT) during a presentation to investors at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco today. The presentation outlined the company's continued focus on creating long-term value in healthcare through its three key strategies of therapy innovation, globalization and economic value. The pending acquisition of Covidien was also highlighted, which is expected to close in the last week of January or early February and is expected to meaningfully accelerate Medtronic's three strategies and increase the company's financial strength and flexibility. The company remains focused on combining reliable performance with disciplined capital allocation to create long-term shareholder value.
MDT: 74.47 (+0.07), JPM: 58.83 (-0.51)
Earnings Season Kicks Off Tonight: Here's What To Expect
Leigh Drogen - at Seeking Alpha - Mon Jan 12, 11:58AM CST
Earnings season unofficially kicks off today after the closing bell when Alcoa (NYSE: AA ) releases results for the fourth quarter. Current estimates paint a picture of two earnings seasons in a couple of regards. Yes, profit growth is expected to...
FDX: 172.57 (-0.09), NKE: 95.86 (-0.13), C: 50.38 (-0.40), BAC: 16.68 (-0.30), WFC: 52.05 (-0.63), UPS: 109.64 (+0.04), T: 33.49 (+0.09), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), GILD: 101.21 (-1.00), MCD: 93.01 (-0.20), VZ: 47.08 (+0.32), AAPL: 109.25 (-2.76), YUM: 72.91 (-0.55)
JP Morgan Healthcare Conference Roundup
Motley Fool Staff - Motley Fool - Mon Jan 12, 11:20AM CST
Source: J.P. Morgan The annual JPMorgan Healthcare Conference, often called the Superbowl of biotech, kicks off this week. The Motley Fool has you covered with reports on company presentations and themes from the conferences. Check back daily...
JPM: 58.83 (-0.51)
American Express Among Nomura's 6 Financial Stock Picks for 2015
at The Street - Mon Jan 12, 10:51AM CST
American Express and Wells Fargo are among Nomura's favored financial stocks ahead of fourth-quarter earnings.
DFS: 63.02 (-0.30), JPM: 58.83 (-0.51), AXP: 89.50 (-0.92), USB: 42.56 (-0.40), MTB: 118.07 (-0.78), WFC: 52.05 (-0.63), BAC: 16.68 (-0.30), PNC: 86.16 (-0.61)
US stocks head lower; crude oil price falls again
By MATTHEW CRAFT - AP - 2 mins ago
NEW YORK (AP) — Falling oil prices dragged the stock market lower on Monday as Exxon Mobil, Chevron and other big energy companies sank along with crude.
ABC: 90.93 (-2.07), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), XOM: 90.33 (-1.77), TIF: 89.01 (-14.44), CVX: 105.88 (-2.33)
ProNAi to Present at the 33rd Annual J.P. Morgan Healthcare Conference
CNW Group - 26 mins ago
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi(®) platform, today announced that it has been invited to present at the 33(rd) Annual J.P. Morgan Healthcare Conference being held this week in San Francisco. Dr. Nick Glover, President and CEO of ProNAi, will provide an update on the Company's development program for its lead DNAi therapeutic, PNT2258, on January 15, 2015 at 11:30 a.m. PST in room Elizabethan D.
JPM: 58.83 (-0.51)
Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
Business Wire - 27 mins ago
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.
JPM: 58.83 (-0.51), GILD: 101.21 (-1.00)
Universal Corp. (UVV) Continues to Strengthen Balance Sheet - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 52 mins ago
Last week, Universal Corporation completed its new bank credit facility agreement.
RAI: 65.64 (+0.66), JPM: 58.83 (-0.51), STI: 38.41 (-0.41), UVV: 39.33 (-0.09)
Burlington Stores, Inc. Announces Secondary Offering of Common Stock
Business Wire - 55 mins ago
Burlington Stores, Inc. (NYSE:BURL) (the "Company"
announced today that affiliates of Bain Capital Partners, LLC and certain other stockholders intend to offer 12,500,000 shares of the Company's common stock in an underwritten public offering. The offering consists entirely of secondary shares to be sold by the selling stockholders. The Company will not sell any shares in the offering and will not receive any proceeds from the offering. JPM: 58.83 (-0.51), BURL: 49.29 (+1.29)
Skilled Healthcare Group and Genesis HealthCare to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 15, 2015
PR Newswire - 1 hr 12 mins ago
Skilled Healthcare Group, Inc. (NYSE: SKH) today announced that Robert Fish, Chief Executive Officer of Skilled Healthcare Group and George V. Hager, Jr., Chief Executive Officer of Genesis HealthCare, LLC, are scheduled to present at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at 9:30 am Pacific Time. The conference is being held at the Westin St. Francis Hotel, San Francisco, CA.
JPM: 58.83 (-0.51), SKH: 8.61 (+0.25)
Aircastle Announces Pricing of $500 Million Aggregate Principal Amount of Senior Notes
PR Newswire - 1 hr 12 mins ago
Aircastle Limited (NYSE: AYR) ("Aircastle"
announced today the pricing of $500 million aggregate principal amount of 5.50% senior notes due 2022 (the "notes" . The notes were priced at par. Aircastle plans to use the net proceeds of the offering for general corporate purposes, which may include repayment of indebtedness. JPM: 58.83 (-0.51), DB: 28.23 (-0.01), AYR: 20.48 (+0.31)
Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration
GlobeNewswire - 1 hr 15 mins ago
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that its collaboration partner Celgene Corporation has agreed that it will exercise its option to obtain an exclusive license outside the United States for AG-120, a first-in-class, oral, potent inhibitor of the mutant IDH1 protein under the terms of the 2010 collaboration agreement. This would be the second IDH mutant inhibitor to be licensed by Celgene in less than a year. AG-120 is currently being evaluated in two Phase 1 dose escalation trials, one in advanced hematologic malignancies and the other in advanced solid tumors. Both trials are evaluating AG-120 in patients whose cancer harbors an IDH1 mutation. The first data from the AG-120 program were presented at the EORTC-NCI-AACR Symposium on November 19, 2014 in advanced hematologic malignancies. Agios expects to report the first data from the Phase 1 advanced solid tumor trial at a medical conference in 2015. Celgene's exercise of the option is subject to receipt of any required regulatory approvals including any applicable clearance under the Hart-Scott-Rodino Act. Agios is webcasting its corporate presentation from the 33 Annual J.P. Morgan Healthcare Conference today at 2:30 p.m. PST (5:30 p.m. EST). The presentation will be followed by a webcast of its question and answer session at 3:00 p.m. PST (6:00 p.m. EST).
JPM: 58.83 (-0.51), AGIO: 131.55 (+3.43), CELGZ: 3.41 (+0.13)
Dynavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - 1 hr 21 mins ago
Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 15, 2015 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
DVAX: 18.58 (+0.87), JPM: 58.83 (-0.51)
Earnings Season Arrives but Markets Can't Stop Worrying About Oil
at The Street - 1 hr 23 mins ago
The earnings season officially kicks off this afternoon with the release of Alcoa AA quarterly earnings, but oil prices remain at the forefront of traders' minds.
C: 50.38 (-0.40), XOM: 90.33 (-1.77), WFC: 52.05 (-0.63), SN: 8.56 (-0.32), BAC: 16.68 (-0.30), INTC: 36.60 (-0.16), AA: 16.17 (+0.06), GS: 185.07 (-2.28), RDS.A: 62.93 (-1.29), JPM: 58.83 (-0.51), BBG: 9.42 (-0.70), REXX: 2.94 (-0.74), BP: 36.05 (-0.53), BAS: 5.44 (-0.66), CVX: 105.88 (-2.33)
Looking Ahead Of Wall Street: J.P Morgan Chase, Bank Of America, Citigroup
TipRanks - Seeking Alpha - 1 hr 26 mins ago
By Carly Forster Wall Street has an exciting week ahead as investment banks are scheduled to announce their fourth quarter fiscal 2014 earnings reports. J.P Morgan Chase: J.P Morgan Chase (NYSE: JPM ) is set to announce their fourth quarter...
JPM: 58.83 (-0.51), C: 50.38 (-0.40), BAC: 16.68 (-0.30)
Obama: With tech advances come privacy risks for US
By NEDRA PICKLER - AP - 1 hr 30 mins ago
WASHINGTON (AP) — President Barack Obama on Monday proposed strengthening laws against identity theft by requiring notification when consumer information is hacked and protecting students' private data.
JPM: 58.83 (-0.51), TGT: 76.63 (+0.20)
JPMorgan to Settle Bear Stearns Mortgage Case for $500M? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 47 mins ago
2015 started on a positive note for JPMorgan as far as the resolution of litigation issues is concerned. After settling a lawsuit for foreign exchange market price manipulation last week, the bank is on the verge of resolving another case.
JPM: 58.83 (-0.51), AMG: 201.59 (-3.75), WAL: 25.58 (-0.43), NAVI: 20.17 (-0.37)
Millions more people to get their credit score for free
By JOSEPH PISANI - AP - 2 hrs 1 min ago
NEW YORK (AP) — Millions more people will have free access to their FICO credit score this year. That's good news for consumers, since the number is widely used by lenders to check potential borrowers' financial health.
DFS: 63.02 (-0.30), COF: 79.06 (-0.31), JPM: 58.83 (-0.51), ALLY: 22.57 (-1.31), C: 50.38 (-0.40), FICO: 70.96 (-0.87), BAC: 16.68 (-0.30)
Do Rising Auto Delinquencies Spell Trouble Ahead?
ETFguide - Seeking Alpha - Mon Jan 12, 12:04PM CST
By Ronald Delegge Is consumer credit quality deteriorating? TransUnion reports: While delinquency levels for subprime borrowers have grown from 4.2% in Q3 2012 to 4.5% in Q3 2013 to 5.3% in Q3 2014, the contribution of this segment to the...
COF: 79.06 (-0.31), JPM: 58.83 (-0.51), ALLY: 22.57 (-1.31), XLY: 70.51 (-0.38), CARZ: 36.92 (-0.08), WFC: 52.05 (-0.63)
Medtronic Highlights Growth Opportunities at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Mon Jan 12, 12:00PM CST
SAN FRANCISCO -- Jan. 12, 2015 -- Chairman and CEO Omar Ishrak discussed the future of Medtronic, Inc. (NYSE: MDT) during a presentation to investors at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco today. The presentation outlined the company's continued focus on creating long-term value in healthcare through its three key strategies of therapy innovation, globalization and economic value. The pending acquisition of Covidien was also highlighted, which is expected to close in the last week of January or early February and is expected to meaningfully accelerate Medtronic's three strategies and increase the company's financial strength and flexibility. The company remains focused on combining reliable performance with disciplined capital allocation to create long-term shareholder value.
MDT: 74.47 (+0.07), JPM: 58.83 (-0.51)
Earnings Season Kicks Off Tonight: Here's What To Expect
Leigh Drogen - at Seeking Alpha - Mon Jan 12, 11:58AM CST
Earnings season unofficially kicks off today after the closing bell when Alcoa (NYSE: AA ) releases results for the fourth quarter. Current estimates paint a picture of two earnings seasons in a couple of regards. Yes, profit growth is expected to...
FDX: 172.57 (-0.09), NKE: 95.86 (-0.13), C: 50.38 (-0.40), BAC: 16.68 (-0.30), WFC: 52.05 (-0.63), UPS: 109.64 (+0.04), T: 33.49 (+0.09), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), GILD: 101.21 (-1.00), MCD: 93.01 (-0.20), VZ: 47.08 (+0.32), AAPL: 109.25 (-2.76), YUM: 72.91 (-0.55)
JP Morgan Healthcare Conference Roundup
Motley Fool Staff - Motley Fool - Mon Jan 12, 11:20AM CST
Source: J.P. Morgan The annual JPMorgan Healthcare Conference, often called the Superbowl of biotech, kicks off this week. The Motley Fool has you covered with reports on company presentations and themes from the conferences. Check back daily...
JPM: 58.83 (-0.51)
American Express Among Nomura's 6 Financial Stock Picks for 2015
at The Street - Mon Jan 12, 10:51AM CST
American Express and Wells Fargo are among Nomura's favored financial stocks ahead of fourth-quarter earnings.
DFS: 63.02 (-0.30), JPM: 58.83 (-0.51), AXP: 89.50 (-0.92), USB: 42.56 (-0.40), MTB: 118.07 (-0.78), WFC: 52.05 (-0.63), BAC: 16.68 (-0.30), PNC: 86.16 (-0.61)
